TFF Pharmaceuticals, Inc.
TFF Pharmaceuticals, Inc.（TFFP）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · TFFP · 截至 2026年6月9日
活动摘要
买入笔数
13
P-Purchase only
卖出笔数
2
近12个月
买卖比
6.50
Buy/Sell (by trades)
整体情绪
TFF Pharmaceuticals, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
TFFP 季度内部人买卖趋势
TFFP 内幕交易卖出 · TFFP 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
TFFP 高管卖出股份 · TFFP 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jul 3, 2024 | Weisman Harlan F President and CEO · Director | Award | 27,480 | — | Form 4 |
| Jul 3, 2024 | Lee Catherine Chai-zon Director | Award | 1,583 | — | Form 4 |
| Jul 3, 2024 | MILLS ROBERT S Director | Award | 3,165 | — | Form 4 |
| Jul 3, 2024 | Roberts Brandi Director | Award | 3,165 | — | Form 4 |
| Jul 3, 2024 | COLEMAN KIRK ALLEN CFO | Award | 10,184 | — | Form 4 |
| Jul 3, 2024 | Mikhak Zamaneh Chief Medical Officer | Award | 10,184 | — | Form 4 |
| Jul 3, 2024 | ROCAMBOLI STEPHEN Director | Award | 3,165 | — | Form 4 |
| Jul 3, 2024 | KING THOMAS BRAXTON Director | Award | 1,583 | — | Form 4 |
| Aug 16, 2023 | CARLSON CAPITAL L P 10 percent owner | Sale | 1,000 | $392 | Form 4 |
| Aug 15, 2023 | Weisman Harlan F President and CEO · Director | Purchase | 600,000 | $150K | Form 4 |
| Aug 15, 2023 | ROCAMBOLI STEPHEN Director | Purchase | 20,000 | $5K | Form 4 |
| Aug 15, 2023 | Roberts Brandi Director | Purchase | 20,000 | $5K | Form 4 |
| Aug 15, 2023 | COLEMAN KIRK ALLEN CFO | Purchase | 20,000 | $5K | Form 4 |
| Aug 15, 2023 | MILLS ROBERT S Director | Purchase | 40,000 | $10K | Form 4 |
| Aug 15, 2023 | Mikhak Zamaneh Chief Medical Officer | Purchase | 120,000 | $30K | Form 4 |
| Mar 10, 2023 | ROCAMBOLI STEPHEN Director | Purchase | 13,000 | $10K | Form 4 |
| Mar 10, 2023 | COLEMAN KIRK ALLEN CFO | Purchase | 12,000 | $9K | Form 4 |
| Mar 10, 2023 | Weisman Harlan F President and CEO · Director | Purchase | 150,000 | $132K | Form 4 |
| Mar 10, 2023 | Mikhak Zamaneh Chief Medical Officer | Purchase | 15,000 | $12K | Form 4 |
| Dec 15, 2022 | Weisman Harlan F President and CEO | Purchase | 50,000 | $53K | Form 4 |
| Nov 22, 2022 | Fletcher Aaron G.L. Director | Purchase | 43,470 | $50K | Form 4 |
| Sep 29, 2022 | THURMAN RANDY H Director | Sale | 40,255 | $173K | Form 4 |
| May 18, 2022 | Weisman Harlan F Director | Purchase | 4,615 | $25K | Form 4 |
| May 18, 2022 | Weisman Harlan F Director | Purchase | 2,500 | $13K | Form 4 |
| May 16, 2022 | Fletcher Aaron G.L. Director | Purchase | 24,600 | $125K | Form 4 |
Weisman Harlan F
President and CEO · Director
日期
Aug 15
股数
600,000
均价
$0.25
总金额
$150K
Weisman Harlan F
President and CEO · Director
日期
Mar 10
股数
150,000
均价
$0.88
总金额
$132K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 TFFP 内幕交易
TFFP 内幕交易
TFF Pharmaceuticals, Inc.（TFFP）内幕交易数据来源于公司内部人（包括TFFP）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。TFFP内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看TFF Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
TFFP 内幕交易 · 5个问题TFF Pharmaceuticals, Inc.（TFFP）的内部人包括高管和董事，如TFFP等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026